1. Home
  2. PMN vs UG Comparison

PMN vs UG Comparison

Compare PMN & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$14.61

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.62

Market Cap

27.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMN
UG
Founded
2004
1942
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.5M
27.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PMN
UG
Price
$14.61
$6.62
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$42.67
N/A
AVG Volume (30 Days)
442.7K
14.9K
Earning Date
03-30-2026
03-20-2026
Dividend Yield
N/A
7.47%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
N/A
$10,060,322.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.68
Revenue Growth
N/A
N/A
52 Week Low
$6.27
$5.58
52 Week High
$39.75
$11.08

Technical Indicators

Market Signals
Indicator
PMN
UG
Relative Strength Index (RSI) 67.71 49.31
Support Level $8.96 $6.25
Resistance Level $17.40 $7.41
Average True Range (ATR) 1.94 0.31
MACD 0.09 -0.04
Stochastic Oscillator 50.96 32.58

Price Performance

Historical Comparison
PMN
UG

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: